Sorrento Escapes COVID-19 Investor Class Action

By Sarah Jarvis · November 19, 2021, 2:51 PM EST

A California federal judge has dismissed a proposed class action from investors in Sorrento Therapeutics Inc. who claimed the company misled the public about its COVID-19 treatment, finding the investors didn't...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Wasa Medical Holdings v. Sorrento Therapeutics, Inc. et al

Case Number

Court

California Southern

Nature of Suit

Securities/Commodities

Date Filed

May 26, 2020

Recent Articles By Sarah

October 28, 2024
Masimo Sues Founder Over Alleged 'Empty Voting' Scheme
July 19, 2024
DaVita To Pay $34M In Medicare Kickback Whistleblower Suit
June 28, 2024
Ontrak Exec Conviction Shows Trading Plans Aren't Shields
April 15, 2024
Mental Health Co. Cerebral To Pay $7M Over Data Failures
March 12, 2024
2nd Circ. Revives Parts Of McKesson Whistleblower Suit
March 11, 2024
Pfizer Slams Ex-Compliance Officer's Whistleblower Claims
October 10, 2023
Justices Hint At Siding With Whistleblower Against UBS
October 06, 2023
5 Things To Know About High Court Whistleblower Case
September 13, 2023
Biz Groups Urge CFPB To Not Go After Medical Credit Cards
July 28, 2023
The Compliance Chiefs Who've Faced Legal Hot Water In '23